234 related articles for article (PubMed ID: 33407864)
1. The potential therapy with dental tissue-derived mesenchymal stem cells in Parkinson's disease.
Xiao Z; Lei T; Liu Y; Yang Y; Bi W; Du H
Stem Cell Res Ther; 2021 Jan; 12(1):5. PubMed ID: 33407864
[TBL] [Abstract][Full Text] [Related]
2. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease.
Zhang L; Yang H
Mol Biol Rep; 2024 Feb; 51(1):347. PubMed ID: 38400887
[TBL] [Abstract][Full Text] [Related]
3. The Importance of Stem Cells Isolated from Human Dental Pulp and Exfoliated Deciduous Teeth as Therapeutic Approach in Nervous System Pathologies.
Candelise N; Santilli F; Fabrizi J; Caissutti D; Spinello Z; Moliterni C; Lancia L; Delle Monache S; Mattei V; Misasi R
Cells; 2023 Jun; 12(13):. PubMed ID: 37443720
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Mesenchymal Stem Cells as a Multitarget Disease- Modifying Therapy for Parkinson's Disease.
Unnisa A; Dua K; Kamal MA
Curr Neuropharmacol; 2023; 21(4):988-1000. PubMed ID: 35339180
[TBL] [Abstract][Full Text] [Related]
5. Diverse Approaches toward Application of Dental Pulp Stem Cells from Human Permanent and Deciduous Teeth in the Treatment of Diabetes.
Kanafi MM; Bhonde RR
Curr Diabetes Rev; 2024; 20(1):e210323214822. PubMed ID: 36959149
[TBL] [Abstract][Full Text] [Related]
6. Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?
Nasrolahi A; Shabani Z; Sadigh-Eteghad S; Salehi-Pourmehr H; Mahmoudi J
Curr Stem Cell Res Ther; 2024; 19(2):185-199. PubMed ID: 36815638
[TBL] [Abstract][Full Text] [Related]
7. Progress in direct reprogramming of dopaminergic cell replacement therapy.
Zheng YY; Xu H; Wang YS
Neurol Sci; 2024 Mar; 45(3):873-881. PubMed ID: 37945931
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of uninduced and neuronally-induced human dental pulp stromal cells in a 6-OHDA model of Parkinson's disease.
Azevedo EM; Fracaro L; Hochuli AHD; Ilkiw J; Bail EL; Lisboa MO; Rodrigues LS; Barchiki F; Correa A; Capriglione LGA; Brofman PRS; Lima MMS
Cytotherapy; 2024 Apr; ():. PubMed ID: 38739074
[TBL] [Abstract][Full Text] [Related]
9. Unravelling the Parkinson's puzzle, from medications and surgery to stem cells and genes: a comprehensive review of current and future management strategies.
Chandrababu K; Radhakrishnan V; Anjana AS; Rajan R; Sivan U; Krishnan S; Baby Chakrapani PS
Exp Brain Res; 2024 Jan; 242(1):1-23. PubMed ID: 38015243
[TBL] [Abstract][Full Text] [Related]
10. Banking on teeth - Stem cells and the dental office.
Zeitlin BD
Biomed J; 2020 Apr; 43(2):124-133. PubMed ID: 32381462
[TBL] [Abstract][Full Text] [Related]
11. Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells.
Pantcheva P; Reyes S; Hoover J; Kaelber S; Borlongan CV
Expert Rev Neurother; 2015 Oct; 15(10):1231-40. PubMed ID: 26394528
[TBL] [Abstract][Full Text] [Related]
12. Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson's Disease.
Cha Y; Park TY; Leblanc P; Kim KS
J Mov Disord; 2023 Jan; 16(1):22-41. PubMed ID: 36628428
[TBL] [Abstract][Full Text] [Related]
13. Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons.
Boroujeni ME; Gardaneh M
Neural Regen Res; 2017 Jul; 12(7):1186-1192. PubMed ID: 28852404
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic Cell Replacement for Parkinson's Disease: Addressing the Intracranial Delivery Hurdle.
Maheshwari S; Akram H; Bulstrode H; Kalia SK; Morizane A; Takahashi J; Natalwala A
J Parkinsons Dis; 2024; 14(3):415-435. PubMed ID: 38457149
[TBL] [Abstract][Full Text] [Related]
15. Exosomes from Human Periapical Cyst-MSCs: Theranostic Application in Parkinson's Disease.
Tatullo M; Marrelli B; Zullo MJ; Codispoti B; Paduano F; Benincasa C; Fortunato F; Scacco S; Zavan B; Cocco T
Int J Med Sci; 2020; 17(5):657-663. PubMed ID: 32210716
[TBL] [Abstract][Full Text] [Related]
16. Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease.
Fričová D; Korchak JA; Zubair AC
NPJ Regen Med; 2020 Nov; 5(1):20. PubMed ID: 33298940
[TBL] [Abstract][Full Text] [Related]
17. Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report.
Vij R; Prossin A; Tripathy M; Kim H; Park H; Cheng T; Lotfi D; Chang D
Front Neurol; 2023; 14():1257080. PubMed ID: 37840944
[TBL] [Abstract][Full Text] [Related]
18. Stem Cell-Based Approaches in Parkinson's Disease Research.
Kim MS; Yoon S; Choi J; Kim YJ; Lee G
Int J Stem Cells; 2024 Mar; ():. PubMed ID: 38449089
[TBL] [Abstract][Full Text] [Related]
19. Stem cell-based approach for the treatment of Parkinson's disease.
Goodarzi P; Aghayan HR; Larijani B; Soleimani M; Dehpour AR; Sahebjam M; Ghaderi F; Arjmand B
Med J Islam Repub Iran; 2015; 29():168. PubMed ID: 26000262
[TBL] [Abstract][Full Text] [Related]
20. A brief perspective on neural cell therapy.
Pruszak J
Mol Cell Ther; 2014; 2():2. PubMed ID: 26056571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
